SAN DIEGO, Feb. 17, 2016 -- The Shareholders Foundation, Inc. announces that a lawsuit was filed in Connecticut on behalf of certain purchasers of shares of CIGNA Corporation (NYSE:CI) over alleged Securities Laws Violations by CIGNA Corporation (NYSE:CI).
Investors who purchased shares of CIGNA Corporation (NYSE:CI) have certain options and for certain investors there are short and strict deadlines running. Deadline: April 6, 2016. NYSE:CI investors should contact the Shareholders Foundation at [email protected] or call +1 (858) 779-1554.
The plaintiff claims that Defendants allegedly made certain false and/or misleading statements and/or failed to disclose that Cigna’s appeals and grievances procedures were not in compliance with federal standards, that Cigna’s noncompliance with federal standards posed a serious threat to the health and safety of Medicare beneficiaries, and that as a result of the foregoing, Cigna’s public statements were materially false and misleading at all relevant times.
On January 22, 2016, CIGNA Corporation announced that on January 21, 2016 it was notified by the Centers for Medicare & Medicaid Services ("CMS") of its intent to impose intermediate sanctions suspending the enrollment of and marketing to new customers of all Cigna Medicare Advantage and Standalone Prescription Drug Plan Contracts.
Those who purchased CIGNA Corporation (NYSE:CI) shares should contact the Shareholders Foundation, Inc. by e-mail at [email protected] or call +1 (858) 779-1554.
The Shareholders Foundation, Inc. is a professional portfolio legal monitoring and a settlement claim filing service, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. The Shareholders Foundation, Inc. is not a law firm. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
CONTACT: Shareholders Foundation, Inc. Michael Daniels +1 (858) 779-1554 [email protected] 3111 Camino Del Rio North Suite 423 San Diego, CA 92108


Waymo Plans Safety and Emergency Response Upgrades After San Francisco Robotaxi Disruptions
TSMC Honors Japanese Chip Equipment Makers With 2025 Supplier Awards
BlackRock-Backed Global Ports Deal Faces Uncertainty Amid Cosco Demands
Hyundai Recalls Over 51,000 Vehicles in the U.S. Due to Fire Risk From Trailer Wiring Issue
South Korean Court Clears Korea Zinc’s $7.4 Billion U.S. Smelter Project, Shares Surge
Saks Global Weighs Chapter 11 Bankruptcy Amid Debt Pressures and Luxury Retail Slowdown
Hanwha Signals Readiness to Build Nuclear-Powered Submarines at Philly Shipyard for U.S. Navy
Boeing Wins $2.04B U.S. Air Force Contract for B-52 Engine Replacement Program
California DMV Proposes New Safety Rules for Autonomous Vehicles After Waymo Incidents
Eli Lilly and Novo Nordisk Battle for India’s Fast-Growing Obesity Drug Market
Texas App Store Age Verification Law Blocked by Federal Judge in First Amendment Ruling
John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio
DOJ Reaches Settlement With Blackstone’s LivCor Over Alleged Rent Price-Fixing
Nvidia to Acquire Groq in $20 Billion Deal to Boost AI Chip Dominance
Warner Bros. Discovery Shares Slide Amid Report of Potential Paramount Skydance Lawsuit
GLP-1 Weight Loss Pills Set to Reshape Food and Fast-Food Industry in 2025 



